BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26188095)

  • 1. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines.
    Vethakanraj HS; Babu TA; Sudarsanan GB; Duraisamy PK; Ashok Kumar S
    Biochem Biophys Res Commun; 2015 Aug; 464(3):833-9. PubMed ID: 26188095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ERα.
    Vethakanraj HS; Sesurajan BP; Padmanaban VP; Jayaprakasam M; Murali S; Sekar AK
    Anticancer Drugs; 2018 Jan; 29(1):50-60. PubMed ID: 29023248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
    Flowers M; Fabriás G; Delgado A; Casas J; Abad JL; Cabot MC
    Breast Cancer Res Treat; 2012 Jun; 133(2):447-58. PubMed ID: 21935601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
    Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
    Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis in prostate cancer cells by the novel ceramidase inhibitor ceranib-2.
    Kus G; Kabadere S; Uyar R; Kutlu HM
    In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1056-63. PubMed ID: 26170224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ceranib-2 on cell survival and TNF-alpha in colon cancer cell line.
    Baspinar M; Ozyurt R; Kus G; Kutlay O; Ozkurt M; Erkasap N; Kabadere S; Yasar NF; Erkasap S
    Bratisl Lek Listy; 2017; 118(7):391-393. PubMed ID: 28766347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
    Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
    Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway.
    Elumalai P; Gunadharini DN; Senthilkumar K; Banudevi S; Arunkumar R; Benson CS; Sharmila G; Arunakaran J
    Toxicol Lett; 2012 Nov; 215(2):131-42. PubMed ID: 23089555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
    Roh JL; Park JY; Kim EH; Jang HJ
    Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ceramidase inhibition on human renal cell carcinoma: a cell culture study.
    Palit F; Vejselova Sezer C; Kutlu HM
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(5 Suppl):121-129. PubMed ID: 37869957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
    Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
    Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining impacts of ceranib-2 on the proliferation, morphology and ultrastructure of human breast cancer cells.
    Vejselova D; Kutlu HM; Kuş G
    Cytotechnology; 2016 Dec; 68(6):2721-2728. PubMed ID: 27380965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic effect of noscapine in breast cancer cell lines.
    Quisbert-Valenzuela EO; Calaf GM
    Int J Oncol; 2016 Jun; 48(6):2666-74. PubMed ID: 27081867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
    Somers-Edgar TJ; Rosengren RJ
    Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
    Furlong SJ; Mader JS; Hoskin DW
    Oncol Rep; 2006 May; 15(5):1385-90. PubMed ID: 16596215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
    Choi YH; Yoo YH
    Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative and apoptosis-inducing activity of nobiletin against three subtypes of human breast cancer cell lines.
    Chen C; Ono M; Takeshima M; Nakano S
    Anticancer Res; 2014 Apr; 34(4):1785-92. PubMed ID: 24692711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells.
    Im JY; Park H; Kang KW; Choi WS; Kim HS
    Chem Biol Interact; 2008 Apr; 172(3):235-44. PubMed ID: 18313654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.
    Morad SA; Cabot MC
    Biochim Biophys Acta; 2015 Sep; 1851(9):1134-45. PubMed ID: 25964209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.